Literature DB >> 23943496

The cost-effectiveness of using financial incentives to improve provider quality: a framework and application.

Rachel Meacock1, Søren Rud Kristensen, Matt Sutton.   

Abstract

Despite growing adoption of pay-for-performance (P4P) programmes in health care, there is remarkably little evidence on the cost-effectiveness of such schemes. We review the limited number of previous studies and critique the frameworks adopted and the narrow range of costs and outcomes considered, before proposing a new more comprehensive framework, which we apply to the first P4P scheme introduced for hospitals in England. We emphasise that evaluations of cost-effectiveness need to consider who the residual claimant is on any cost savings, the possibility of positive and negative spillovers, and whether performance improvement is a transitory or investment activity. Our application to the Advancing Quality initiative demonstrates that the incentive payments represented less than half of the £ 13 m total programme costs. By generating approximately 5200 quality-adjusted life years and £ 4.4 m of savings in reduced length of stay, we find that the programme was a cost-effective use of resources in its first 18 months.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  Cost-effectiveness; Pay-for-performance

Mesh:

Year:  2013        PMID: 23943496     DOI: 10.1002/hec.2978

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

1.  Capsule commentary on Goetz et al., The effect of charge display on cost of care and physician practice behaviors: a systematic review.

Authors:  Rosa Rodriguez-Monguio
Journal:  J Gen Intern Med       Date:  2015-06       Impact factor: 5.128

2.  Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.

Authors:  Hui-Min Hsieh; Song-Mao Gu; Shyi-Jang Shin; Hao-Yun Kao; Yi-Chieh Lin; Herng-Chia Chiu
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 3.  Does performance-based financing increase value for money in low- and middle- income countries? A systematic review.

Authors:  Anne-Marie Turcotte-Tremblay; Jessica Spagnolo; Manuela De Allegri; Valéry Ridde
Journal:  Health Econ Rev       Date:  2016-07-29

4.  Should interventions to reduce variation in care quality target doctors or hospitals?

Authors:  Nils Gutacker; Karen Bloor; Chris Bojke; Kieran Walshe
Journal:  Health Policy       Date:  2018-04-13       Impact factor: 2.980

Review 5.  Framework for patient, family-centred care within an Australian Community Hospital: development and description.

Authors:  Thuy Frakking; Suzanne Michaels; Jane Orbell-Smith; Lance Le Ray
Journal:  BMJ Open Qual       Date:  2020-04

6.  Modelling the cost-effectiveness of pay-for-performance in primary care in the UK.

Authors:  Ankur Pandya; Tim Doran; Jinyi Zhu; Simon Walker; Emily Arntson; Andrew M Ryan
Journal:  BMC Med       Date:  2018-08-29       Impact factor: 8.775

7.  Healthcare at the Beginning of Life and Child Survival: Evidence from a Cash Transfer Experiment in Nigeria.

Authors:  Edward N Okeke; Isa S Abubakar
Journal:  J Dev Econ       Date:  2019-11-22

8.  Withdrawing performance indicators: retrospective analysis of general practice performance under UK Quality and Outcomes Framework.

Authors:  Evangelos Kontopantelis; David Springate; David Reeves; Darren M Ashcroft; Jose M Valderas; Tim Doran
Journal:  BMJ       Date:  2014-01-27

9.  Examination of the Synthetic Control Method for Evaluating Health Policies with Multiple Treated Units.

Authors:  Noémi Kreif; Richard Grieve; Dominik Hangartner; Alex James Turner; Silviya Nikolova; Matt Sutton
Journal:  Health Econ       Date:  2015-10-07       Impact factor: 3.046

10.  Estimating causal effects: considering three alternatives to difference-in-differences estimation.

Authors:  Stephen O'Neill; Noémi Kreif; Richard Grieve; Matthew Sutton; Jasjeet S Sekhon
Journal:  Health Serv Outcomes Res Methodol       Date:  2016-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.